Home About Us
About Milestone

Milestone Biological Science & Technology Co.,Ltd. is a company dedicated to the pharmaceutical industry, a high-tech enterprise integrating R&D, production and sales. Since its inception in 2014, Milestone® Biotechnologies has focused on the R&D and provision of national brand cellular models by building the self-own brand TPCSs - The Primary Cell Solution. In order to break the United States, Europe and other developed countires' monopoly on cell technology and the Chinese market, TPCS aims to implement import substitution and energize Chinese domestic innovative drug R&D industry.

Headquartered in Zhangjiang Science City, Shanghai, Milestone® Biotechnologies has R&D and production centers in Beijing, Guangdong and Zhejiang as well as offices and partners in major provinces of the country which establishing a wide service network radiating the whole country.

Mission:Provide Integrated Solutions Based on Primary Cells
Vision:Drive Pharmaceutical Innovation for a Healthy Future
Independent R&D Brand

2014

Established in

5000

m2
Laboratory

1200

+
Partners

30

%
Investment
Management Team
Zhang Jinbao
CEO
Dr. Huang Binlu
CSO
He Xiaoting
COO
Zhang Jinbao
CEO

An outstanding alumnus of Jiangxi University of Chinese Medicine.
Over 20 years of life science upstream entrepreneurship and working experience in marketing and sales management.
Good at market strategy formulation and product market access for biomedical enterprises.

Main social duties:
Member of the 6th CPPCC Committee of Putuo District, Zhoushan City
Director of Shanghai Jiangxi Chamber of Commerce
Member of Shanghai Pudong Chamber of Commerce
Director of Zhangjiang Science City Chamber of Commerce
Executive Vice President of Zhoushan Jiangxi Chamber of Commerce
Vice President of Shanghai Alumni Association of Jiangxi University of Chinese Medicine

Dr. Huang Binlu
CSO

Ph.D. in Cell Biology, Tsinghua University, postdoctoral research at the University of Basel and the Chinese Academy of Sciences.
Formerly served in Imunopharm Technology, responsible for the research and development of CAR-T solid tumor drugs.
Formerly founded CellX, a cellular agriculture company, serving as a co-founder and R&D leader.
Currently serving as CSO of Milestone, responsible for front-end research and development.

He Xiaoting
COO

Master’s degree in neurobiology of Fudan University.
With rich practical experience in business development, team building and collaboration among various departments.
Currently serving as COO of Milestone, responsible for coordinating product, production, quality, clinical and intellectual property management, communication and coordination.

History
2014

• Milestone Biological Science & Technology Co.,Ltd. was established, Shanghai R&D center was launched, and began to develop products and technologies related to primary cell.

2017

• BSL-2 pathogenic microbiology laboratory was approved by the National Health Commission of People’s Republic of China.

2018

• Milestone Zhejiang office was established, with a nearly 2,000 square meters of R&D and production service base.
• Milestone was awarded as a high-tech enterprise.

2019

• Shanghai High-tech Achievement Transformation Project Certification

2020

• Shanghai "specialized and special new" small and medium-sized enterprises
• Certified as the Pudong New District enterprise R&D organization

2021

• Outstanding Enterprise Award of China Innovation and Entrepreneurship Competition (Growth Group)

2022

• In January 2022, Milestone Beijing subsidiary settled in Daxing Biomedical Industry Base
• In June 2022, Milestone Shenzhen subsidiary was put into operation

2023

•In 2023, Milestone Bio has obtained a round of venture capital investment with an amount exceeding 100 million RMB.

Future

Moving forward, we are unstoppable

2014

2017

2018

2019

2020

2021

2022

2023

Future

News&Updates
Careers
Post
Quantity
Work Place
Salary
Release Time
Business Development Director
1
USA
DP
2024.02.04

Responsibility

1. Responsible for business cooperation and development with overseas agents and end customers, implementing sales targets in overseas markets and promoting implementation to achieve expected sales targets;

2. Understand industry trends and seek potential partners who can meet the overseas business needs of company, leading the establishment of cooperative relationships, and developing overseas markets;

3. Understand information about the overseas bio-pharmaceutical industry and conduct research on the latest information and trends in overseas markets, providing intelligence and analysis for the company's overseas strategy formulation, and participating in the formulation of targeted strategies and plans for the company;

4. Participate in international business and academic conferences, representing the company to establish effective connections with industry clients and peers;

5. Support the completion of other tasks assigned by superiors.

Qualification

1. More than 3-5 years of work experience in the biological industry, with sales experience in Biopharma and Biotech;

2.With a master's or overseas MBA degree in biological science, pharmacology, or related fields will be given priority consideration;

3.Experience in business development, search and evaluation, management consulting, market research, corporate strategy, or investment in the field of life sciences;

4. Having communicative English skills in listening, speaking, reading, and writing, as well as certain business communication and negotiation skills (English can be used as a reporting language), with overseas study or work experience;

5. Having a deep understanding of foreign markets, experience in new business development, and business negotiation skills;

6. Having a certain level of stress resistance, daring to challenge new businesses, and having innovative ideas for expanding overseas business;

7. Adapt to international business trips, with a focus on European and American regions.